Skip to main content

FDA Link Insomnia Drugs to Impaired Alertness

By Jim Greene

The Food & Drug Administration (FDA) is warning those who take insomnia drugs before bedtime to lower the dosage. The recommendation is prompted by the fact that insomnia drugs taken at night can impair alertness and safe driving up until the next morning’s commute.

New data on prescription insomnia treatments marketed under the brand names Zolpidem, Ambien, Ambien CR, Edluar, and Zolpimist show that patients still suffer impaired attentiveness the morning after a bedtime dosage—especially women who eliminate the drug from their bodies slower than men.

Thus far the FDA has asked manufacturers of these generic and brand names to lower the recommended doses of the prescription drugs.

Source: Fox News

Jim Greene

Contributor

Jim has spent the last 5 years writing for a variety of health-related websites. At Activebeat, James is an essential member of the editorial team, providing information on exercise, diet & nutrition and men’s health – among many other things.

Latest Health Recalls

Explore

Yoga: Modern Research Shows a Variety of Benefits to Both Body and Mind From the Ancient Practice
By Herpreet Thind Your Health

Yoga: Modern Research Shows a Variety of Benefits to Both Body and Mind From the Ancient Practice

The popularity of yoga has grown tremendously in the past decade. More than 10% of U.S. adults have practiced yoga at some point in their lives. Yoga practitioners spend on average US$90 a month, and the yoga industry is worth more than $80 billion worldwide. Yoga is now a mainstream activity in the U.S. and […]

Read More about Yoga: Modern Research Shows a Variety of Benefits to Both Body and Mind From the Ancient Practice

5 min read